MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT07505745
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Sponsor
- Hudson Biotech
- Registry
-
NCT07505745
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07505745. Randomized; quadruple masking; primary purpose treatment. Start 2026-02-02 (actual); primary completion 2027-02-14 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity
- Acronym
- MOTS-MET
- Condition
- Prediabetes
- Condition
- Insulin Resistance
- Condition
- Overweight/Obesity
- Intervention (Drug)
- MOTS-c (MDP)
- Intervention (Drug)
- Placebo
- Intervention (Other)
- Route Subcutaneous injection
- Intervention (Other)
- Regimen
- Lead sponsor
- Hudson Biotech
Record details
- Record id
cardio:ct-nct07505745- Content hash
a87d208daf30a49fdd4da7eee97fce7dc899d085cd6b765065b2fa6d6dfd7659